![S. Robert Blair](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
S. Robert Blair
Geen lopende functies
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Edward A. Taylor | M | 81 |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 13 jaar |
Christopher Henney | M | 83 |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 13 jaar |
W. Vickery Stoughton | M | 78 |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 18 jaar |
Richard L. Jackson | M | 84 |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 14 jaar |
D. Kirkpatrick | M | 67 |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
Robert L. Kirkman | M | 75 |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 1 jaar |
Eric Edward Baker | M | - |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
Michael C. Welsh | M | 81 |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 20 jaar |
Robert D. Aubrey | M | - |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 17 jaar |
Guy Ely | M | 71 |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
Ronald J. Helmhold | M | - |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 11 jaar |
Marilyn Olson | F | - |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 18 jaar |
Jane H. Tulloch | F | - |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
Gary W. Christianson | M | 69 |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
Bill Wickson | M | - |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | - |
R. Rao Koganty | M | 81 |
Biomira, Inc.
![]() Biomira, Inc. Medical/Nursing ServicesHealth Services Biomira, Inc. engages in the research and development of therapeutic products for the treatment of cancer. The company focuses on developing synthetic vaccines and novel strategies for cancer immunotherapy | 21 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Canada | 16 | 100.00% |
Verenigde Staten | 4 | 25.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- S. Robert Blair
- Persoonlijk netwerk